HLS THERAPEUTICS INC (HLS.CA) Stock Analyst Ratings
TSX:HLS - Toronto Stock Exchange - CA40390B1094 - Common Stock - Currency: CAD
ChartMill assigns a Buy % Consensus number of 76% to HLS.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.74. This target is 14.75% above the current price.
HLS.CA was analyzed by 9 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about HLS.CA.
In the previous month the buy percentage consensus was at a similar level.
HLS.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-11 | Stifel Nicolaus Research | Downgrade | |
| 2022-10-26 | Stifel Nicolaus Research | Maintains | Buy |
| 2022-08-25 | Raymond James Capital | Downgrade | Outperform |
| 2022-08-12 | Stifel Nicolaus Research | Downgrade | |
| 2022-05-06 | Raymond James Capital | Initiate | Outperform |
| 2022-04-27 | Clarus Securities | Reiterate | Buy |
| 2022-04-27 | Raymond James Capital | Upgrade | Outperform |
| 2022-03-21 | Clarus | Initiate | Buy |
| 2022-03-20 | Raymond James Capital | Initiate | Outperform |
| 2022-03-20 | Canaccord Capital | Downgrade | Buy |
| 2022-03-15 | Raymond James Capital | Initiate | Outperform |
| 2022-03-10 | Stifel Nicolaus Research | Initiate | Buy |
| 2021-12-16 | Raymond James Financial | Initiate | Outperform |
| 2021-11-05 | RJ Financial | Initiate | Outperform |
| 2021-10-28 | Raymond James Financial | Initiate | Outperform |
| 2021-08-17 | Raymond James Financial | Upgrade | Outperform |